NSC
53
2
BDX
60
3
DAL
79
2
AAP
32
2
DNB
60
2
PBI
55
-5
ECL
84
-3
MDT
60
3
EXC
47
3
ROP
65
-3
APD
57
-3
UAL
60
3
HOG
35
2
ROK
40
-10
NWS
83
8
MCO
77
-3
CCL
43
3
EFX
74
2
SIG
78
5
HSIC
56
12
NSC
53
2
BDX
60
3
DAL
79
2
AAP
32
2
DNB
60
2
PBI
55
-5
ECL
84
-3
MDT
60
3
EXC
47
3
ROP
65
-3
APD
57
-3
UAL
60
3
HOG
35
2
ROK
40
-10
NWS
83
8
MCO
77
-3
CCL
43
3
EFX
74
2
SIG
78
5
HSIC
56
12
Financhill
Back

Avalo Therapeutics Stock Predictions

BREAKING: Elon Musk's Secret A.I. Project Set to Plunge Millions of Americans Into Poverty

Click here now to prepare yourself for what's around the corner
Sell
17

AVTX
Avalo Therapeutics

Last Price:
10.82
Seasonality Move:
-8.46%

7 Day Trial

ALL ACCESS PASS

$ 7

This DeFi Coin Could 10x Soon... I Advise You Get In Now!

Discover this DeFi diamond before the next surge

Avalo Therapeutics Stock Forecast

  • Over the next 52 weeks, Avalo Therapeutics has on average historically risen by 33.4% based on the past 8 years of stock performance.
  • Avalo Therapeutics has risen higher in 3 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 37.5%
  • Is Avalo Therapeutics Stock Undervalued?
    The current Avalo Therapeutics [AVTX] share price is $10.82. The Score for AVTX is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
  • AVTX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Avalo Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Avalo Therapeutics has on average historically risen by 33.4% based on the past 8 years of stock performance.

Avalo Therapeutics Stock Rating

Sell
17
Avalo Therapeutics (AVTX) is a Sell

Is Avalo Therapeutics overpriced?

  • Avalo Therapeutics has risen higher in 3 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 37.5%

Avalo Therapeutics Stock Price History

Is AVTX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AVTX is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Sector:
Type:
stock
Website:
avalotx.com

52-Week Data

52-Week High:
1,130.40
52-Week Low:
3.95

Prediction Charts

Market Cap:
11.19M
Price in USD:
10.82
Volume:
51.76K
Beta:
1.39

Technical Analysis

SMA50:
11.14
SMA100:
8.68
SMA200:
18.23
52-Wk Change:
-98.17%

Stock Predictions

  • Is Avalo Therapeutics stock public?
    Yes, Avalo Therapeutics is a publicly traded company.
  • What is the Avalo Therapeutics stock quote today?
    The Avalo Therapeutics stock price is 10.82 USD today.
  • How to buy Avalo Therapeutics stock online?
    You can buy Avalo Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-24 13.00 14.20 14.25 12.80
Apr-25 13.95 14.98 16.32 13.65
Apr-26 15.00 15.94 16.23 14.69
Apr-29 16.00 16.88 17.49 15.68
Apr-30 16.58 17.12 17.15 16.01
May-1 17.10 16.00 17.10 14.70
May-2 16.20 15.39 17.42 15.39
May-3 15.58 14.36 16.00 13.15
May-6 14.36 13.50 14.99 13.27
May-7 13.50 13.50 13.76 13.14
May-8 13.20 11.73 13.20 11.25
May-9 11.87 11.49 12.71 11.49
May-10 11.49 10.85 11.59 10.35
May-13 10.66 10.82 11.20 10.63

Avalo Therapeutics Earnings

Avalo Therapeutics Earnings Report: Per Share Avalo Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Avalo Therapeutics Forecast Revenue Growth

Avalo Therapeutics Stock Analysis: Historical quarterly revenues per share for Avalo Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.41 per share, and a decrease next year of $0.00 per share.

* Avalo Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.